Global Blood Therapeutics, Inc. Contracts & Agreements

66 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture, dated as of October 5, 2022, between Global Blood Therapeutics, Inc. and U.S. Bank Trust Company, National Association, as trustee
Indenture Agreements
Global Blood Therapeutics, Inc.
2022
Amendment No. 1 to License Agreement by and between the Registrant and Sanofi, dated April 15, 2022
License Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2022
Agreement and Plan of Merger, dated as of August 7, 2022, among Pfizer Inc., Ribeye Acquisition Corp. and Global Blood Therapeutics, Inc
Merger Agreements
Global Blood Therapeutics, Inc.
2022
Amended and Restated U.S. Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
2022
Amended and Restated Severance and Change in Control Policy
Change of Control Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2022
Non-Employee Director Compensation Policy
Compensation Agreements
Global Blood Therapeutics, Inc.
2022
Indenture, dated as of December 17, 2021, between Global Blood Therapeutics, Inc. and U.S. Bank National Association, as trustee
Indenture Agreements
Global Blood Therapeutics, Inc.
2021
Form of Capped Call Transaction Confirmation
Global Blood Therapeutics, Inc.
2021
Employment Offer Letter Agreement by and between the Registrant and Carrie Krehlik, dated June 15, 2021
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2021
Employment Offer Letter Agreement by and between the Registrant and Kim Smith-Whitley, M.D., dated November 24, 2020
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2021
License Agreement by and between the Company and Sanofi, dated March 12, 2021
License Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2021
Amended and Restated 2015 Stock Option and Incentive Plan and forms of award agreements thereunder
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2021
Amended and Restated Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
2021
Amended and Restated 2017 Inducement Equity Plan and forms of award agreements thereunder
Global Blood Therapeutics, Inc.
Biotechnology
DE
2021
Amended and Restated Severance and Change in Control Policy
Change of Control Agreements
Global Blood Therapeutics, Inc.
2021
Non-Employee Director Compensation Policy
Compensation Agreements
Global Blood Therapeutics, Inc.
2021
Amended and Restated 2017 Inducement Equity Plan and forms of award agreements thereunder
Global Blood Therapeutics, Inc.
Biotechnology
DE
2020
Amended and Restated Severance and Change in Control Policy (amended and restated through May 26, 2020)
Change of Control Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2020
Amended and Restated 2015 Employee Stock Purchase Plan
Stock Agreements
Global Blood Therapeutics, Inc.
2020
Non-Employee Director Compensation Policy, as amended and restated on March 24, 2020
Compensation Agreements
Global Blood Therapeutics, Inc.
2020
Description of Securities
Global Blood Therapeutics, Inc.
2020
License and Collaboration Agreement by and between the Registrant and Syros Pharmaceuticals, Inc., dated December 17, 2019
Collaboration Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2020
Loan Agreement by and among the Registrant, BioPharma Credit PLC, and Biopharma Credit Investments V (Master) LP, dated December 17, 2019
Loan Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2020
Amended and Restated Severance and Change in Control Policy
Change of Control Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2020
Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2020
Change in Control Policy
Change of Control Agreements
Global Blood Therapeutics, Inc.
2019
Employment Offer Letter by and between the Registrant and Eric Fink, dated June 17, 2019
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2019
Underwriting Agreement dated June 26, 2019 by and between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2019
Employment Offer Letter by and between the Registrant and Jung Choi, dated March 16, 2015
Employment Agreements
Global Blood Therapeutics, Inc.
2019
Non-Employee Director Compensation Policy
Compensation Agreements
Global Blood Therapeutics, Inc.
2019
Employment Offer Letter by and between the Registrant and Brian Cathers, Ph.D., dated January 21, 2019
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2019
Underwriting Agreement dated December 7, 2018 by and between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co., as representative of the several underwriters
Underwriting Agreements
Global Blood Therapeutics, Inc.
2018
Amendment between the Company and HCP, dated August 29, 2018
Global Blood Therapeutics, Inc.
Biotechnology
2018
Change in Control Policy
Change of Control Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2018
Employment Offer Letter Agreement by and between Registrant and Peter Radovich, dated October 15, 2014
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2018
Employment Offer Letter Agreement by and between Registrant and Jung Choi, dated March 16, 2015
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2018
Employment Offer Letter Agreement by and between Registrant and David Johnson, dated February 21, 2018
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2018
Underwriting Agreement dated March 8, 2018 by and between Global Blood Therapeutics, Inc. and Wells Fargo Securities, LLC, as representative of the several underwriters
Underwriting Agreements
Global Blood Therapeutics, Inc.
2018
Underwriting Agreement dated December 15, 2017 by and between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co., as representative of the several underwriters
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2017
Global Blood Therapeutics, Inc. (the Company) Change in Control Policy Adopted on July 23, 2015 (amended on January 6, 2016, July 5, 2017 and July 26, 2017)
Change of Control Agreements
Global Blood Therapeutics, Inc.
2017
THE COVE AT OYSTER POINT LEASE
Lease Agreements
Global Blood Therapeutics, Inc.
2017
400 East Jamie Court Suite 101 South San Francisco, CA94080 ###-###-#### f ###-###-#### www.globalbloodtx.com
Global Blood Therapeutics, Inc.
2017
GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO, CA 94080
Global Blood Therapeutics, Inc.
Biotechnology
2017
5,102,041 Shares GLOBAL BLOOD THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2017
SUBLEASE
Lease Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2016
Pricing Term Sheet [None.]
Term Sheets
Global Blood Therapeutics, Inc.
2016
GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO, CA 94080
Global Blood Therapeutics, Inc.
2016
GLOBAL BLOOD THERAPEUTICS, INC. FIRST AMENDMENT TO AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
Global Blood Therapeutics, Inc.
2016
GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO, CA 94080
Global Blood Therapeutics, Inc.
Biotechnology
2016
Exhibit 10.6
Global Blood Therapeutics, Inc.
2016
GLOBAL BLOOD THERAPEUTICS, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2016
[] Shares Global Blood Therapeutics, Inc. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT [], 2015
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2015
Additional abbreviations may also be used though not in the above list.
Global Blood Therapeutics, Inc.
2015
GLOBAL BLOOD THERAPEUTICS, INC. 2015 STOCK OPTION AND INCENTIVE PLAN
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
2015
GLOBAL BLOOD THERAPEUTICS, INC. DIRECTOR INDEMNIFICATION AGREEMENT
Indemnification Agreements
Global Blood Therapeutics, Inc.
2015
GLOBAL BLOOD THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2015
GLOBAL BLOOD THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
Global Blood Therapeutics, Inc.
Biotechnology
CA
2015
GLOBAL BLOOD THERAPEUTICS, INC. 2012 STOCK OPTION AND GRANT PLAN
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2015
GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 575 SOUTH SAN FRANCISCO, CA 94080
Global Blood Therapeutics, Inc.
Biotechnology
2015
GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 575 SOUTH SAN FRANCISCO, CA 94080
Global Blood Therapeutics, Inc.
2015
LEASE AGREEMENT
Lease Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2015
ASSIGNMENT AND ASSUMPTION OF LEASE (400 East Jamie Court)
Lease Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2015
LEASE AGREEMENT
Lease Agreements
Global Blood Therapeutics, Inc.
2015
400 East Jamie Court Suite101 South San Francisco, CA 94080 t (650) 741-770 f ###-###-#### www.globalbloodtx.com
Global Blood Therapeutics, Inc.
2015
400 East Jamie Court Suite101 South San Francisco, CA 94080 t (650) 741-770 f ###-###-#### www.globalbloodtx.com
Global Blood Therapeutics, Inc.
Biotechnology
2015
400 East Jamie Court Suite101 South San Francisco, CA 94080 t (650) 741-770 f ###-###-#### www.globalbloodtx.com
Global Blood Therapeutics, Inc.
Biotechnology
2015